The new group “Technologies for Bioelectronic Medicine” will start its activities in September 2018. The aim is to develop a platform technology for electroceuticals. These are intelligent, customizable micro-implants that can target certain regions of the nervous system. The micro-implants need to fit to the anatomy of the targeted sites and furthermore bear up the aggressive conditions in the human body.

The micro-implants are smaller than 1 cm3 and have stimulating, biomarker sensing and neural recording possibilities.

Bioelectronic Medicines aim to treat a number of diseases, such as diabetes, hypertension or migraine. They deliver local and reversible therapy, avoiding the side effects of conventional drugs.

The new group is led by the specialist in bioelectronics medicine Dr. Vasiliki Giagka.